Brief: ADC Therapeutics SA Files For Resale Of Up To 4.4 Million Common Shares By Selling Shareholders - SEC Filing
06/09/2022 22:23
Sept 6 (Reuters) - ADC Therapeutics SA ADCT.N :
* ADC THERAPEUTICS SA FILES FOR RESALE OF UP TO 4.4 MILLION
COMMON
SHARES BY SELLING SHAREHOLDERS - SEC FILING
Source: [https://bit.ly/3D364SE]
Further company coverage: ADCT.N
Recent news on ADC Therapeutics SA
See all newsADC Therapeutics plunges after patient deaths in blood cancer drug trial
ADC Therapeutics falls on higher rates of serious side-effects in cancer trial
Switzerland's ADC Therapeutics beats Q1 revenue estimates
Switzerland's ADC Therapeutics posts smaller‑than‑expected Q4 net loss on lower R&D spend
Brief: ADC Therapeutics Q4 Income From Operations USD -17.919 Million Vs. IBES Estimate USD -30.1 Million